{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:39:56Z","timestamp":1793932796785,"version":"4.8.0"},"reference-count":17,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,4,27]],"date-time":"2010-04-27T00:00:00Z","timestamp":1272326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p><jats:bold>Purpose:\u2002<\/jats:bold> The purpose of this study was to investigate the tolerability and intraocular pressure (IOP) reducing effect of the first preservative\u2010free prostaglandin tafluprost (Taflotan<jats:sup>\u00ae<\/jats:sup>) in patients exhibiting ocular surface side\u2010effects during latanoprost (Xalatan<jats:sup>\u00ae<\/jats:sup>) treatment.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> A total of 158 patients were enrolled in this open\u2010label multicentre study. Eligible patients had to have at least two ocular symptoms, or one sign and one symptom, during treatment with latanoprost. At baseline, the patients were directly switched from latanoprost to preservative\u2010free tafluprost for 12\u2003weeks. The patients were queried for ocular symptoms, and ocular signs were assessed by using tear break\u2010up time, Schirmer\u2019s test, fluorescein staining and evaluation of conjunctival hyperaemia and blepharitis. In addition, HLA\u2010DR and MUC5AC in conjunctival impression cytology specimens were analyzed, and a drop discomfort\/quality of life (QoL) questionnaire was employed. IOP was measured at all visits.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Preservative\u2010free tafluprost maintained IOP at the same level after 12\u2010\u2003weeks treatment (16.4\u2003\u00b1\u20032.7\u2003mmHg) as latanoprost at baseline (16.8\u2003\u00b1\u20032.5\u2003mmHg). During treatment with preservative\u2010free tafluprost, the number of patients having irritation\/burning\/stinging (56.3%), itching (46.8%), foreign body sensation (49.4%), tearing (55.1%) and dry eye sensation (64.6%) decreased to 28.4%, 26.5%, 27.1%, 27.1% and 39.4% correspondingly. The number of the patients with abnormal fluorescein staining of cornea (81.6%) and conjunctiva (84.2%), blepharitis (60.1%), conjunctival hyperaemia (84.2%) and abnormal Schirmer\u2019s test (71.5%) was also reduced significantly to 40.6%, 43.2%, 40.6%, 60.0% and 59.4% correspondingly. The tear break\u2010up time improved significantly from 4.5\u2003\u00b1\u20032.5\u2003seconds to 7.8\u2003\u00b1\u20034.9\u2003seconds. A reduction in the number of patients with abnormal conjunctival cells based on HLA\u2010DR and MUC5AC was also detected.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Preservative\u2010free tafluprost maintained IOP at the same level as latanoprost, but was better tolerated in patients having signs or symptoms while on preserved latanoprost. Preservative\u2010free tafluprost treatment resulted in improved QoL, increased patient satisfaction and drop comfort.<\/jats:p>","DOI":"10.1111\/j.1755-3768.2010.01907.x","type":"journal-article","created":{"date-parts":[[2010,4,28]],"date-time":"2010-04-28T21:53:21Z","timestamp":1272491601000},"page":"329-336","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":119,"title":["Switching from a preserved to a preservative\u2010free prostaglandin preparation in topical glaucoma medication"],"prefix":"10.1111","volume":"88","author":[{"given":"Hannu","family":"Uusitalo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Brignole\u2010Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kaarniranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Leino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Puska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Palmgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hamacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auli","family":"Ropo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,4,27]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(97)30314-5"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90116-1"},{"key":"e_1_2_8_4_1","first-page":"90","article-title":"Flow cytometric analysis of inflammatory markers in KCS : 6\u2010month treatment with topical cyclosporine A","volume":"42","author":"Brignole F","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2003.08.005"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.77.9.590"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1994.01090230060021"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2008.01381.x"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067210701700311"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.26.1691"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.4.418"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.03-1067"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(92)32001-9"},{"key":"e_1_2_8_14_1","first-page":"865","article-title":"The influence of topically applied anti\u2010glaucomatous eye drops on conjunctival cell differentiation","volume":"88","author":"Steuhl KP","year":"1991","journal-title":"Fortschr Ophthalmol"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2006.0061"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.5414\/CPP46400"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2003.12.007"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2008.01380.x"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-3768.2010.01907.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1755-3768.2010.01907.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T20:58:01Z","timestamp":1697403481000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1755-3768.2010.01907.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,27]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1755-3768.2010.01907.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1755-3768.2010.01907.x","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,27]]},"assertion":[{"value":"2010-04-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}